The Saudi Stock Exchange (Tadawul) recorded a significant decline in profits for Al Hammadi Holding Company during the 2025 fiscal year. Financial data showed a 28.7% decrease, with net profits reaching SAR 241.86 million, compared to SAR 338.8 million in the previous year, 2024. This decline necessitates a deeper analysis of the company's financial and operational policies in light of current economic shifts and its expansion plans.
The trajectory and evolution of healthcare and its impact on Al Hammadi Company's profits
Al Hammadi Holding Company is a cornerstone of the healthcare sector in Saudi Arabia. Since its inception, the company has played a pivotal role in providing advanced medical services, keeping pace with the rapid population growth and urban development in the capital city of Riyadh. With the launch of Vision 2030, the government has increased its focus on privatizing the healthcare sector and encouraging private investment to improve the quality of life and provide comprehensive and advanced medical care for citizens and residents.
This historical context and national focus explain the company's ongoing commitment to developing its infrastructure. Investing in the healthcare sector requires substantial capital and long-term planning, which sometimes impacts short-term financial results. The company's management prioritizes future expansion and asset building over immediate profit margins, thus justifying recent financial actions.
The main reasons behind the decline in financial performance in 2025
According to the official statement issued by the company and published on the Saudi Stock Exchange (Tadawul) website, this decrease in net profit can be attributed to several fundamental factors related to operational and investment activities, which are as follows:
- Absence of non-recurring gains: The annual comparison was significantly affected by the absence of exceptional gains recorded in 2024, amounting to SAR 55.27 million as a result of the sale of a strategic piece of land in the Al Rayyan district of Riyadh.
- Increased operating costs: The company experienced a significant increase in operating costs and human resources costs, as a direct result of the group’s strategic direction towards expanding its services, particularly in the medical services and pharmaceutical product retail sectors.
- Increased administrative and marketing expenses: General and administrative expenses, in addition to sales and marketing expenses, increased by a total of SAR 19.64 million. This step supports the service diversification strategy aimed at achieving sustainable growth in future revenues.
- Credit loss provisions: The provision for expected credit losses increased to SAR 21.11 million during 2025, compared to approximately SAR 9.07 million in the previous year. This is due to the delay in collecting some receivables from a number of the company’s major clients.
- Impairment of goodwill: The financial results included an impairment of goodwill resulting from the investment in some subsidiaries amounting to SAR 4.30 million.
- Decrease in financing income: Financing income declined to SAR 3.77 million, as a result of the management’s decision to consume part of the available cash balances to accelerate the pace of construction work in the “Al Hammadi Hospital Al Ulya” project and ensure speed of completion.
Economic dimensions and the impact of expansions on the local and regional market
Despite the temporary decline in figures, the strategic steps taken by Al Hammadi Holding have significant economic implications at both the local and regional levels. Locally, the accelerated construction of Al Hammadi Hospital and the expansion of its pharmacy network are creating hundreds of new job opportunities for Saudi nationals, in addition to meeting the steadily increasing demand for specialized healthcare in the Kingdom.
Regionally, strengthening the medical infrastructure enhances the Kingdom's competitiveness as a leading medical tourism destination in the Middle East. The decision to allocate a portion of current profits to build sustainable healthcare assets reflects strategic maturity, as financial experts anticipate that these expansions will generate strong cash flows and stable operating revenues once the new projects are fully operational. This will bolster the company's position in the financial market and support the national economy as a whole.
